Allarity Therapeutics: Funding, Investors & Team (Oct 2026)
Allarity Therapeutics is a biopharmaceutical company that focuses on creating cancer treatments that are personalized to each patient. They use advanced technology to predict how patients will respond to different drugs, which helps improve the selection process and outcomes of clinical trials. The company's product pipeline includes several promising treatments such as Dovitinib, which is used to treat renal cell carcinoma, Stenoparib, a dual PARP inhibitor, and Tankyrase Inhibitor, which targets ovarian cancer. They also develop IXEMPRA, a microtubulin inhibitor that is effective in treating metastatic breast cancer.
Allarity Therapeutics has raised $31.0M across 2 funding rounds on record, the most recent an undisclosed round of $20.0M announced in Mar 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Allarity Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Allarity Therapeutics Funding Rounds
Allarity Therapeutics raised $11.0M in an undisclosed round announced in Jul 2023.
2.7 years later, an undisclosed round of $20.0M was announced in Mar 2026.
Allarity Therapeutics Founders and Leadership Team
Contact details for the Allarity Therapeutics team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Allarity Therapeutics Funding Compared to Other Biotechnology Startups
Allarity Therapeutics' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Allarity Therapeutics in Biotechnology and Boston
Companies Similar to Allarity Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Allarity Therapeutics Funding FAQs
What does Allarity Therapeutics do?
Allarity Therapeutics is a biopharmaceutical company that focuses on creating cancer treatments that are personalized to each patient. They use advanced technology to predict how patients will respond to different drugs, which helps improve the selection process and outcomes of clinical trials. The company's product pipeline includes several promising treatments such as Dovitinib, which is used to treat renal cell carcinoma, Stenoparib, a dual PARP inhibitor, and Tankyrase Inhibitor, which targets ovarian cancer. They also develop IXEMPRA, a microtubulin inhibitor that is effective in treating metastatic breast cancer.
How much funding has Allarity Therapeutics raised?
Allarity Therapeutics has raised $31.0M across 2 rounds on record. The most recent is an undisclosed round of $20.0M announced in Mar 2026.
When did Allarity Therapeutics last raise funding?
Allarity Therapeutics' most recent funding round on record is an undisclosed round of $20.0M, announced in Mar 2026.
Who founded Allarity Therapeutics?
FundedIQ lists Steen Knudsen (Founder), Thomas Jensen (Founder) at Allarity Therapeutics.
Where is Allarity Therapeutics headquartered?
Allarity Therapeutics is based in Boston, Massachusetts, United States.
How many employees does Allarity Therapeutics have?
Allarity Therapeutics is in the 11-50 employee band.
How does Allarity Therapeutics' funding compare to other Biotechnology startups?
Allarity Therapeutics' latest round of $20.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Allarity Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Allarity Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.